Pfizer Expands Obesity Portfolio with US$4.9 B Acquisition of Metsera
By Shikha Kashyap
Pharma Deals Review: Vol 2025 Issue 10 (Table of Contents)
Published: 3 Oct-2025
DOI: 10.3833/pdr.v2025.i10.2972 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to catch up in the booming obesity field, Pfizer has agreed to acquire Metsera for an initial enterprise value of US$4...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS